FOUNDER MANIFESTO · SCIENCE-FIRST · EVIDENCE-BASED MEDICINE
Most Doctors Distrust Supplements. They Are Right To.
Olympia Biosciences™ Exists to Close the Knowledge Gap Between Pharma and Nutraceuticals.
A categorical rejection of marketing-led supplementation, written by an M.Sc. Eng. in Applied Physics and Applied Mathematics (Double Specialization: Abstract Quantum Physics & Organic Microelectronics) and Ph.D. Candidate in Medical Sciences (Phlebology), who refuses to authorise what the peer-reviewed record cannot defend. This is the operating doctrine, in plain language, for clinicians and operators who treat "science-first" and "evidence-based medicine" as obligations, not slogans.
THE GUARANTEE IS STRUCTURAL. THE EVIDENCE IS PUBLIC. ↓
THE FOUR PILLARS OF EVIDENCE-BASED FORMULATION
How a Composition Becomes a Defended Scientific Position.
Four independent verification layers separate an Olympia formulation from a catalogue product. Each layer is gated; a recipe that fails any one of them is rejected before tooling.
PROPRIETARY AI MODEL
Cocktail-Effect Elimination, Trained on Peer-Reviewed Literature.
A founder-built AI screening engine — endorsed by the Polish National Centre for Research and Development (NCBR) and trained on thousands of peer-reviewed papers — interrogates every recipe for adverse synergistic load, antagonism between actives, and contraindications with prescription drug classes. Operating to the same logic used in pharmaceutical formulation review, it ships its full interaction matrix with every dossier.
SPECIALIST LEGAL REVIEW
We Only Declare What We Can Defend.
Every formulation is independently audited by a legal team specialised in dietary supplement and food-for-medical-purposes law. EFSA-approved health claims are the floor — not the ceiling. Where the science exceeds the regulatory text, we file substantiation; where the regulatory text exceeds the science, we strike the claim. No marketing language survives that audit.
EVIDENCE DOSSIER
Every Client Receives the Bibliography Behind the Composition.
A complete, citation-grade bibliography accompanies each formulation — drawn from PubMed-indexed Class A medical journals — documenting the published evidence that justifies every active, every dose, and every excipient choice. The composition is a hypothesis only as long as it is undocumented; once shipped, it is a defended scientific position.
STABILITY ENGINEERING
A Supplement That Oxidises in the Bottle Is a Marketing Object, Not a Therapeutic One.
Seventeen years of technical production discipline informs how we engineer stability: omega TOTOX control to keep PUFAs from oxidising, probiotic strain segregation to prevent antagonistic co-cultures, cold-chain protocols where the molecule demands them. Most factories stay silent on these failure modes. We treat them as the primary specification.
METHOD PROVES RIGOUR. WHAT FOLLOWS PROVES THE OPERATOR. ↓
ORIGIN — IN THE FOUNDER\u2019S OWN WORDS
"Many physicians are reluctant to prescribe supplements. As a Ph.D. Candidate in Medical Sciences (Phlebology), a licensed phytotherapist, and an M.Sc. Eng. in Applied Physics and Applied Mathematics (Double Specialization: Abstract Quantum Physics & Organic Microelectronics) — I understand why. There is much on this market I will not sign my name to. Olympia Biosciences was founded out of that refusal — at the intersection of medicine, technology, and a disciplined, healthy life."
— Olimpia Baranowska M.Sc. Eng. (Applied Physics & Applied Mathematics · Abstract Quantum Physics & Organic Microelectronics) · Ph.D. Candidate in Medical Sciences (Phlebology) · Founder & Scientific Director
A Founder Who Reads the Physics, the Pharmacology, and the Botany.
Olympia\u2019s scientific gates are not delegated to a contracted consultant. The technical, clinical, and botanical literacy required to refuse a flawed formulation is held inside the founder seat — and reinforced by 17 years of technical CDMO operations with zero client QA complaints on record.
PRIMARY DISCIPLINE
TECHNICAL PHYSICS
M.Sc. ENG. · GDAŃSK UNIVERSITY OF TECHNOLOGY | DOUBLE SPECIALIZATION: ABSTRACT QUANTUM PHYSICS & ORGANIC MICROELECTRONICS
CLINICAL TRACK
PHD CANDIDATE
MEDICINE · DOCTORAL STUDIES | SPECIALIZATION: PHLEBOLOGY
BOTANICAL LICENSE
CERTIFIED PHYTOTHERAPIST
LICENSED · PLANT-DERIVED PHARMACOLOGY
OPERATING RECORD
17 YRS · 0
CLIENT QA COMPLAINTS · TECHNICAL PRODUCTION
OPERATOR ESTABLISHED. NOW THE FILTER. ↓
ADMISSION GATE
We Decline More Than 80% of Inbound Mandates — Including the Most Lucrative.
Cost is optimised, never traded against quality. We choose what works — not what carries a brand premium and costs 100× more without published superiority.
Olympia is the convergence of hard business and harder science — an unobvious posture in a category dominated by white-label catalogues and dropship logistics. If you are sourcing the cheapest possible production, this is not the right intake. If you intend to put your name on a product and sleep through the night, the conversation begins here.
For clinicians and operators who treat "science-first" and "evidence-based medicine" as obligations, the work ahead is a shared intellectual mandate — and a long one.
- REJECT CHEAPEST-INPUT FORMULATIONS WHERE THE SAVING ERODES THE ACTIVE
- REJECT BRAND-PREMIUM RAW MATERIALS WHERE THE EVIDENCE IS NOT 100× THE COST
- REJECT CLAIMS THAT EFSA TOLERATES BUT THE PEER-REVIEWED RECORD DOES NOT SUPPORT
- REJECT PROJECTS WHERE COMMERCIAL VELOCITY IS ASKED TO OUTPACE SAFETY DATA
IF THE FILTER READS AS OBVIOUS, THE NEXT BLOCK IS THE INTAKE. ↓
NEXT STEP — PAID DUE DILIGENCE
If This Doctrine Reads as Obvious, You Are the Operator We Build For.
Engagement begins with a paid Discovery scope: clinical objectives, formulation thesis, and regulatory pathway are stress-tested before any production decision. The output is a defensible blueprint. The conversion is to a long shared mission — not to a quote.
RELATED INTELLIGENCE